support@activebiopharma.com
中文版
Menu
Home
Products
Inhibitors
AKT Inhibitors
ALK Inhibitor
ATM Inhibitor
Aurora Kinase Inhibitors
Bcl-2 Protein Family Inhibitors
B-Raf inhibitors
CDK inhibitors
c-Met Inhibitors
EGFR inhibitor
HDAC Inhibitors
Hedgehog inhibitor
HIV Inhibitor
JAK inhibitor
MEK inhibitor
mTOR Inhibitor
PARP inhibitor
PI3K Inhibitor
PKC Inhibitor
PLK1 Inhibitor
Other inhibitors
Activator
Agonist
antagonist
API
Aurora
Metabolic Disease
VEGFR-PDGFR
Other Intermediate
Others
MOF Chemicals
About Us
Custom Synthesis
Order & Payment
Contact Us
RKI-1313
Home
/
Products
/
RKI-1313
RKI-1313
Cat.No.
ABP019849
Chemical Name
RKI-1313
CAS
1342276-76-9
MolFormula
MolWeight
Purity
NLT 98%
Product Detail
Intermediates
Related Products
Chemical Name
: RKI-1313
CAS
: 1342276-76-9
RKI-1313 Negative control for RKI-1447 (GLXC-05200) which is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer.
Enquiry
Name/Company
Email
Subject
Message
Enquiry ABP019849 | RKI-1313 | 1342276-76-9
Captcha
Copyright © 2015-2025 Active Biopharma Corp. All rights reserved. Support by
Moldb
.
浙ICP备11021315号-3
浙公网安备 33010802003999号
Scroll